title: [Cotrimoxazole for toxoplasmosis encephalitis: a cheaper and safer treatment?].
authors.forename: G
authors.initials: G
authors.lastname: Béraud
authors.forename: S
authors.initials: S
authors.lastname: Pierre-François
authors.forename: A
authors.initials: A
authors.lastname: Foltzer
authors.forename: D
authors.initials: D
authors.lastname: Smadja
authors.forename: A
authors.initials: A
authors.lastname: Cabié
mesh_terms: D000890:Anti-Infective Agents / Q000191:economics / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active; D003365:Costs and Cost Analysis; D004660:Encephalitis / Q000188:drug therapy / Q000382:microbiology; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy; D006801:Humans; D012449:Safety; D016781:Toxoplasmosis, Cerebral / Q000150:complications / Q000188:drug therapy*; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000191:economics / Q000627:therapeutic use*
chemical_list: D000890:Anti-Infective Agents; D015662:Trimethoprim, Sulfamethoxazole Drug Combination